The sale of antidepressants and mood elevators in India surged from Rs 1,540 crore in 2020 to Rs 2,536 crore by Nov 2024.

Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...

Johnson & Johnson's Spravato therapy for treatment-resistant depression (TRD) hasn't made the impact the company hoped for in the market, and it is looking to new clinical results to accelerate ...

The market for antidepressants is, however, getting more competitive after years of stagnation, with a string of new drugs on or approaching the market including AbbVie’s Vraylar (cariprazine ...

Is the stock market open on New Year's Eve and New Year's Day? This year, the answer to that question is mixed. New Year's Eve falls on a Tuesday this year which means the stock market is open for ...

Stifel Nicolaus analyst Paul Matteis has maintained their bullish stance on NMRA stock, giving a Buy rating today.Don't Miss Our New Year's ...

Depression occurs in up to two-thirds of patients with stroke, and placebo-controlled trials have shown improvement in post-stroke depressive symptoms with antidepressant drug treatment.

H.C. Wainwright says that while Neumora Therapeutics ’ KOASTAL-1 result “was a surprise and disappointment,” the better results for female patients provide reason to remain ...

Ecotourism isn’t just about responsible travel; it’s about transforming how we interact with the world,” says Dr. Sunil Kariyakarawana, one of the pioneers of Mindfulness-Based Ecotourism (MBET) in ...

Despite being a first-line treatment for adolescent depression and anxiety, antidepressant drugs appear to have questionable efficacy and carry an increased risk of adverse effects in this population.